April 2019 Stock Considerations

As we find ourselves in the month of April I realize it is time for me to outline my potential stock buy(s) for the next few weeks. Looking at my portfolio and seeing what relative good values are out there it seems that I’m considering “more of the same.” These are the stocks that seem to be on the radar of many in the DGI space as we seek to maximize potential returns with high safe yields. With that being said let’s take a look at my April stock considerations.

First, I am looking at Altria Group, Inc. (MO). Though the stock has come back quite nicely from its recent lows I still like the stock under $60. The juicy yield well north of 5% is still well covered and the negative sentiment around the stock has not abated which still might give those wishing to go long the stock some time to make up their mind and pick up some shares. The last time I added to my MO was back in January.

Next, I’m thinking about buying more AT&T Inc. (T), especially if stock prices go to $30 or below. T was my sole purchase in November as prices remain depressed and yields get pushed ever higher. Sure, there are a lot of near term headwinds this company is currently facing, not least of which is its debt load, but, the dividend still appears to be quite safe and can reward patient shareholders over the long haul. T still remains less than 1% of my taxable account and much less when compared to all three of my portfolios. In other words, I’m still comfortable adding to my position.

Finally, I am looking to buy AbbVie Inc. (ABBV). This was my sole purchase in the month of March as I added some shares to my ROTH account. 2019 has been a tough start for the stock and it is once again trading at levels not seen since October of last year. With a sustainable yield pushing well over 5% this long time holding of mine is looking enticing, especially under $80.

See, more of the same. These three stocks have been on my mind for at least the last four months or so. What do you think about my potential stock buys for the month of April? Are you considering any of these names for your own portfolio? Please let me know below.

Disclosure: Long MO, T, ABBV

24 thoughts on “April 2019 Stock Considerations

  1. I’ve started looking into AbbVie and it’s valuation metrics and dividend yield look attractive… but I need to dig into it’s revenue and profit diversification. I’ve always been hesitant to jump into medical companies due to the regulatory environment and intellectual property constraints.

    • Hi FF,

      Well, ABBV has been bumped around a lot in recent months. A lot of it is concern over their Humira expiration. It still has a broad pipeline of drugs and I think the Humira concern is overblown.

  2. I like T/MO,but both of them started upward trend recently.Waiting to see if MO will come down a little.
    I am tracking MMM,ITW,NVDA and maybe adding ABBV before ex dividend date.

    • Hi desidividend,

      MMM seems like a good pick up after their recent drop. Even though MO went up a lot from its recent lows I still like it under $60 and would wait for T to be under $30 before I buy again. Thanks for sharing your picks.

    • Hi MDD,

      CVS and WBA are the two popular names I keep reading about among several others. Looking forward to May I am looking at the same names again and maybe GILD too. Keep on buying!

    • Hi Passivecanadianincome,

      No problems waiting. Looks like May you’ll still have an opportunity to pick up some great names offering good yields. Not every stock has participated in the market rally.

    • Hi DD,

      No secret there. Yield it is. I never liked chasing yield and I hold many, many stocks with much smaller yields, but when you see solid, well known dividend payers like MO, PM, T, ABBV and others yielding between 4% and 6% you have to take notice.

  3. Keith,

    So many good choices out there right now. The market may be up big time, but there are still so many companies that are definitely undervalued relative to what they bring to the table.

    – Gremlin

  4. Nice list Hut! I’m digging it. I own two of the three (T and ABBV) on your listing. As you said on my post, there are still some gems out there to be found despite the highs. I don’t think you can go wrong with any of those choices.

    Bert

    • Hi DD,

      The interesting thing about recent months is that we have many high yield choices out there from traditional dividend payers. We all know the names and to me it seems like a good time to stock up on the likes of T, VZ, MO, PM, ABBV, GILD and others.

    • Hi AAI,

      Nice to see you buying in earnest. I wouldn’t mind adding to my MO as long as it is under $60. GILD has been pretty beaten up in April and is starting to look compelling for a May buy. We’ll see.

    • Hi PIV,

      I’d like to add to my T but only under $30. In the meantime there are plenty of other high yield choices out there. ABBV was my go to stock for March and April and with a beaten up GILD it may be my May buy.

  5. The list definitely looks familiar as I see those names everywhere for the last few months. Out of those 3, I own only T. I think I would choose MO if I had to choose between those 3 choices, as I recently bought some CVS and don’t want to add another healthcare-related company 🙂

    • Hi BI,

      ABBV has been my pick in March and April but I think I may look at MO or GILD more so in May. Of course, it all depends on the price I am waiting for. CVS and WBA have been making the rounds lately too.

    • Hi TI,

      There are many high yield long term picks to choose from these days. In April I went with ABBV though GILD is a close second and I may buy it in May. The yield was over 4% not long ago but has since dropped a bit. Still, it looks attractive to me.

Leave a Comment

CommentLuv badge

This site uses Akismet to reduce spam. Learn how your comment data is processed.